Metabolon

Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle.

The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.

Metabolon headquartered in United States, North America, operates in the Software, Biotechnology, Life Science, Health Care, Health Diagnostics sector. The company focuses on Software and has secured $83.1B in funding across 320 round(s). With a team of 251-500 employees, Metabolon is actively contributing to advancements in Software. Their latest funding round, Series C - Metabolon, raised $6.0M. Discover more about their projects, partnerships, and impact on our platform.